Enlivex Ltd. (ENLV) reporting calendar
Enlivex Ltd. files periodic reports with the SEC as ENLV on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 25 Mar 2026
- Reports on record
- 12
Open ENLV market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 25 Mar 2026 | 84 days | 0001213900-26-033857 |
| 20-F | 31 Dec 2024 | 30 Apr 2025 | 120 days | 0001213900-25-037657 |
| 20-F | 31 Dec 2023 | 30 Apr 2024 | 121 days | 0001213900-24-037878 |
| 20-F | 31 Dec 2022 | 10 Apr 2023 | 100 days | 0001213900-23-028398 |
| 20-F | 31 Dec 2021 | 29 Apr 2022 | 119 days | 0001213900-22-022527 |
| 20-F | 31 Dec 2020 | 30 Apr 2021 | 120 days | 0001213900-21-023865 |
| 20-F | 31 Dec 2019 | 30 Apr 2020 | 121 days | 0001213900-20-010632 |
| 20-F | 31 Dec 2018 | 30 Apr 2019 | 120 days | 0001213900-19-007437 |
| 20-F | 31 Dec 2017 | 23 Apr 2018 | 113 days | 0001144204-18-021827 |
| 20-F | 31 Dec 2016 | 24 Feb 2017 | 55 days | 0001144204-17-011029 |
| 20-F | 31 Dec 2015 | 29 Mar 2016 | 89 days | 0001144204-16-090954 |
| 20-F | 31 Dec 2014 | 31 Mar 2015 | 90 days | 0001144204-15-019667 |
Source: SEC EDGAR company submissions for CIK 0001596812. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.